Gröschel, S., Sanders, M. A., Hoogenboezem, R., Zeilemaker, A., Havermans, M., Erpelinck, C., . . . Valk, P. J. M. (2015). Mutational spectrum of myeloid malignancies with inv(3)/t(3;3) reveals a predominant involvement of RAS/RTK signaling pathways. Blood.
Citación estilo ChicagoGröschel, Stefan, et al. "Mutational Spectrum of Myeloid Malignancies With Inv(3)/t(3;3) Reveals a Predominant Involvement of RAS/RTK Signaling Pathways." Blood 2015.
Cita MLAGröschel, Stefan, et al. "Mutational Spectrum of Myeloid Malignancies With Inv(3)/t(3;3) Reveals a Predominant Involvement of RAS/RTK Signaling Pathways." Blood 2015.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.